List of Bioinformatics Companies in India - 20

Welcome to Advaita, where innovation meets expertise in B2B services. Our expertise lies in 360 degrees solutions to your corporate needs. We specialise in Corporate Events, Corporate training, Data analysis based AI solutions, Market Research, Analytics, Business consulting, Networking and Partnerships. We are a technology driven organization and keep ourselves up to date with the changing trends and market needs. At Advaita, we understand that each client is unique, and our services are tailored to meet your specific needs.

Algorithmic Biologic's vision is to create a bountiful and healthy world by bringing scale efficiencies to molecular discovery and diagnostics. Our transdisciplinary team has a deep modeling-based understanding of the chemistry and mechanics of molecular technologies. Our first product, Tapestry, is award-winning, regulatory approved algorithmic solution to provide affordable large-scale COVID-19 testing.

APAC BIOTECH strives to find roots of cancer - the world's alarming disease, by transforming the promise of technology and knowledge of oncology into therapies that have the power to restore health and even save lives of cancer patients. A Biotechnology Company focused on Research and Manufacturing Of Cell Based Immunotherapy treatment for Cancer

ArrayGen Technologies is a India based Genomics Service provider. The organization was formed in 2014 and has been providing services to clients in India and overseas. We are a continously growing firm with an enthusiastic team dedicated to fullfil all your needs in bioinformatics. We belive in delivering the best and our services persue our motto. We also expertise in online and offline training and workshops. These trainings help the undertaker to gain industrial experience and knowledge that can help them on a great career path in the fields of bioinformatics. Our services specialize in algorithm development,array design, microarray data analysis, NGS data analysis, clinical genomics services, Agrigenomics services, bioinformatics services. ArrayGen's service expands to many international countries including United Kingdom, Israel , United Arab Emirates, Egypt, Jordon etc. In the year 2016, ArrayGen plans to introduce Summer Internships for international and national students. ArrayGen aims to a place you can find all the solutions to your problems....!!!

Later part of the bygone twentieth century has witnessed a major revolution in the field of life-sciences. Researches carried out during this period, particularly in the area of molecular biology and recombinant technology, have led to emergence of 'Biotechnology'​ with a new face. Plants, animals and microorganisms being a key component of our ecosystem have always remained at centre-stage of research for different purposes as they affect the human life. Development of culture methods, better understanding about molecular biology, discovery of restriction endonucleases and their use in mapping of DNA laid the foundation stone for modern day biotechnology. Isolation of thermostable DNA polymerase along with the development of PCR technique made cloning simplified and providing way for rec-DNA technology. Further developments were generation of bar-code like DNA fragment patterns of genomic DNA. These patterns appeared useful in distinguishing individuals based on DNA sequence variations among them. Such variations of DNA among organisms were termed as fingerprints or profiles which provide a versatile tool to characterize genetic variability, genome evolution, population genetics, taxonomy, breeding and diagnostics even today! The technology to read the DNA base-by-base made it possible to identify useful genes. This information which could be cloned in suitable vectors and introduced in appropriate hosts through a variety of gene transfer methods gave an impetus to genetic improvement programmes and production of Genetically modified organisms. Today the genomic sequencing is contributing to identify the basis of pathology, providing tailored therapies. We are quickly advancing towards the in situ engineering of the genomic information to achieve designer humanity. Bioheaven ventures into this space "Turning Human Needs into Careful Solutions"​..........

Cardiotrack is a disruptive healthcare diagnostics solution that is making healthcare delivery more efficient. The mission of Cardiotrack is to reduce the cost of diagnosis by an order of magnitude through innovation in product design, and enhancements in healthcare workflow. Key challenges faced by healthcare providers include – the high cost of diagnostic equipment and lack of trained professionals, especially in semi-urban areas. Cardiotrack is addressing both these issues through the state of the art medical electronics, data analytics, cloud storage and diagnostics workflow management. Cardiotrack focuses on heart health and has consulted with some of the best medical research institutions in India like St John's Research Institute & Jayadeva Institute of Cardiovascular Science in Bangalore; brought onboard doctors and cardiologists as advisers and is collaborating researchers at the Loyola University of Chicago to deliver a comprehensive diagnostics solution for cardiovascular diseases (CVD). Cardiotrack is a multiple parameter handheld diagnostic device including 12-lead ECG monitor, pulse oximeter and blood pressure monitor integrated with mobile-based practice management solution and cloud backend. Low cost, portability and network-connectivity mean that Cardiotrack may be deployed at the primary care level and the resultant scan of the patient can be delivered instantaneously to a specialist anywhere in the world. This approach leads to efficient use of specialists'​ time, enables early diagnosis of heart patients and thus reduces the need for expensive invasive intervention. YouTube: https://www.youtube.com/watch?v=Tj3EI2iC7RE

Recognized as the 'Most Innovative Biotech Company, 2024', by Fast Company! Even today Early R&D, Precision Diagnostics and Translational Biomarker teams spend about 80% of their time wrangling data. Elucidata's mission is to empower scientists in the life sciences field by reclaiming every valuable hour for their research endeavors. Elucidata’s data harmonization platform - Polly, helps research teams make multi-modal biomedical data Machine Learning ready. Each dataset on Polly is processed consistently using pipelines of your choice, is custom curated with granular annotations and undergoes robust QA/QC checks to ensure highest data quality standards. Polly transforms multi-modal and multi-source biomedical data (Omics, Assay, Real World Data, Clinical & EHR Data, and CRO data) into a Unified Data Model. With our 10X faster LLM-powered curation and human-in-the-loop model to achieve 99.99% accuracy, we are fast-tracking time to analysis. Today, Polly is facilitating use case like patient stratification, biomarker discovery, target ID & validation, data management, and development of clinical and commercial pipelines across Pfizer, Janssen Pharmaceuticals, NextGen Jane and IMBDx and over 35 premier biopharma companies and research labs. Head-quarted in San Francisco, we are a 120+ multi-disciplinary team of experts based across the US and India. In September 2022, we raised $16 million in our Series A round led by Eight Roads and F-Prime along with our existing investors Hyperplane and IvyCap. Write to us at info@elucidata.io for queries To talk to us, visit: https://www.elucidata.io/book-a-meeting For more information, visit: https://www.elucidata.io/ Visit Our Offices - San Francisco Head Quarters: 114 Sansome Street, Suite 250 San Francisco, CA 94104 Boston Office: 625 Massachusetts Avenue Cambridge, MA 02139 R&D Hubs, India - Delhi and Bangalore

Jubilant Biosys Ltd (JBL) offers end-to-end CRDMO solutions in Structural Biology, Computational Chemistry, Medicinal & Synthetic Chemistry, in-vitro and in-vivo Biology, DMPK, Toxicology, Process R&D & Manufacturing to various Biotech & Pharma companies pursuing drug discovery, development and manufacturing. Jubilant Biosys Limited (JBL) is a subsidiary of Jubilant Pharmova, serving the global life sciences, agrochemicals and specialty chemicals industry through its research centers & manufacturing facilities in India. Jubilant's services in discovery research include; Jubilant's services in discovery research includes; • Target Identification/Target Validation to Lead Optimization/ Preclinical candidate, for multiple therapeutic areas viz; Oncology, Metabolic Disorders, CNS, Pain and Inflammation. • Functional services comprising of computational chemistry/ molecular modeling, medicinal chemistry, synthetic chemistry, scale-up (Non-GMP & GMP), structural biology, ADME-PK,in-vitro and in-vivo biology and IND enabling GLP toxicology.

Mapmygenome™ uses genomics to personalize health and well-being. Our at-home DNA tests and diagnostic genomic tests provide DNA-based insights that enable consumers, physicians, and health service providers to create a personalized health journey. Established in 2013, Mapmygenome™ has a vision to “Touch 100 million lives and save a million lives by 2030. Some of the preventive genomic tests that Mapmygenome™ offers are Genomepatri, BeautyMap, MyFitGene, Cardiomap, MedicaMap, and MapmyBiome. MapMyGenome also helps people discover their ethnic roots with Genomepatri Heritage.

MedGenome is a genomics-driven research and diagnostics company with a mission to improve global health by decoding the genetic information contained in an individual’s genome. Our powerful genomics solutions accelerate biomarker identification and discovery research for pharma and biotech companies. Our unique access to genomics data with clinical and phenotypic data provides insights into complex diseases at the genetic and molecular level to facilitate research in personalized healthcare. MedGenome Inc. has its Corporate Headquarters and a Next Generation Sequencing (NGS) lab in Foster City, California, US. MedGenome Labs is the market leader for genetic diagnostic testing in India and South Asia. We deliver AI-driven and Validated Genetic testing solutions through new-age proprietary tools and technologies to empower the Clinicians for better management of disease cohorts in rare inherited diseases, reproductive genetics, cancer, eye & neurological disorders, diabetes, cardiovascular diseases and more. Our Genetic Reference Lab at Bangalore is the largest CAP accredited lab in South-East Asia, that offers over 1300 genetic tests across different disease areas such as Oncology, Neurology, Cardiology, Ophthalmology and Rare diseases.

With over two decades of experience in Big Data and Data Science Solutions, Molecular Connections (MC) has been using AI-powered proprietary models to help customers achieve digital transformation. We have been able to successfully build a data-driven decision-making strategy for our customer’s digital transformational journey. MC leverages AI, ML and the Linked Data Store to build efficiencies in various verticals and generate new revenue streams for its customers. MC’s decades of industry presence and a strong focus on innovation have led us to work with the world’s leading pharma and STEM industries to offer end-to-end software development and data insights powered by proprietary workflows and platforms, enabling content engineering across multiple domains. With over 70% of its workforce being women, MC is ranked among the top 15 best companies for women to work for in India. Subsidiary Companies: 1. Molecular Connections Analytics Pvt. Ltd. | URL: https://mcanalytics.co.in/ 2. Molecular Connections Research Pvt. Ltd. | URL: https://mcresearch.co.in/

We are Nexstem. We create Brain-Computer Interface (BCI) solutions that help people interact with technology using their brain signals. Founded in 2020, by Siddhant and Deepansh - engineers with a passion for neuroscience and technology, we've been pushing the boundaries of what's possible in neurotech since our first product, the Nexstem V1 in 2022. At Nexstem, we specialize in non-invasive BCI devices, like our 19-channel headset, Instinct, which comes with a full software ecosystem to decode brain signals. Our goal is to make BCI technology accessible, empowering researchers, clinicians, and developers to innovate and explore new frontiers in brain-computer interaction. Nexstem's technology is recognised by many stalwarts of the industries includes Mircrosoft for Startups, NASSCOM, VIVA tech Paris, YourStory and many more. We have got support from some of the finest neuroscientists and doctors to build accessible tech for the neurotech. We strongly believe in creating value for people and NeuroTech Pulse is our monthly news letter that highlights a news round-up of neurotech industry across the globe, events, case studies and individual spotlights for notable achievers in the field. Do join us on substack - nexstem.substack.com

OneCell Diagnostics, Inc. is a Precision Oncology Liquid Biopsy Diagnostics Company focused on developing the 1st-in-Class, Circulating Tumor Cell (CTC)-based, Single-Cell Multi-omics Lab Developed Tests for applications in clinical cancer care & early-stage clinical trials for Biotech/Pharma companies. ​ OneCell Diagnostics, Inc. is a joint venture between two companies with innovative technologies: Actorius Innovations and Research Pvt Ltd, a leading provider of CTC Tests in India, and Indx.ai, a Silicon Valley based innovative software company specialising in Multi-omics Biomarker Data Analytics.

PopVax is an Indian biotechnology company based in Hyderabad building a novel thermostable, low-cost, and safe second-generation mRNA platform for rationally-designed broadly-protective multi-epitope vaccines. We're starting with an open-source 4-8 °C refrigerator-stable booster candidate that is intended to protect against the entire sarbecovirus sub-family, including current and future strains of SARS-CoV-2 (the virus which causes COVID-19), and some other beta-coronaviruses such as MERS-CoV. PopVax's work has been funded primarily via collaboration with the Bill & Melinda Gates Foundation (India) and Vitalik Buterin's Balvi. Our India-based team of 30 researchers and senior manufacturing leaders includes experts in antigen design, mRNA sequence optimization and synthesis, and nucleic acid delivery from top Indian and North American research institutions, including CCMB, CDFD, IIT Delhi, IAVI, Harvard, Scripps, and UBC, as well as vaccine & biologics production veterans from companies including Sanofi, Biocon, Panacea Biotec and Biological E. The smaller scientific team for our US-based subsidiary, PopVax North America, is led by Moderna's first Director of Chemistry, and includes several leading practitioners of de novo computationally-driven rational protein design for novel vaccine immunogens.

Prantae is the vision of what lies beyond the boundaries of human imagination. It is a leap-of-faith into 'tomorrow of connected technologies' that empowers each one of the human kind to take control his own health and well-being. It is the canvas of every creative scientist, engineer and doctor who desire to change the face of humanity for better wherever in the galaxy humans ever venture to

PREMIER Biosoft is a leading bioinformatics company offering software products and services to government agencies, pharmaceutical and biotechnology companies and academia across the globe. PREMIER Biosoft specializes in software development for life science community. and has products for PCR, Real Time PCR, Mass spectrometry data analysis, Glycomics, Lipidomics, MALDI Imaging, Proteomics and Plasmid drawing. The company also offers custom informatics solutions to life science companies and laboratories. With all these services, the PREMIER Biosoft team promises to extend these benefits to companies, universities and laboratories.

Qure.ai is a breakthrough Artificial Intelligence (AI) solution provider that is disrupting the radiology 'status quo' by enhancing imaging accuracy and providing AI assistance for Accelerated Healthcare. The company uses deep learning and AI to make healthcare more accessible and equitable for patients. Qure AI also provides automated interpretation of radiology exams and ultrasound scans, and has raised a total funding of $56M over 5 rounds from healthcare investors.

RASA is a CRO offering solutions and services in the area of Life sciences. With our combined experience in Bio-informatics and Chemo-informatics and strong advisory board, RASA is set to provide premium services in technology solutions, product development and training. We provide our customers with a seamless model of our wide expertise and comprehensive platforms. We are one of the emerging Bio-IT company based in Pune dealing with broad aspects of life science informatics such as Next generation sequencing, Bioinformatics, Drug discovery, Biological database development, Data curation, etc. Being able to achieve success since our establishment, we are always dedicated to improve our quality of service and bring out best suitable results for you and evolved with best name in the field of life science. We would like to approach for possible collaboration with regards to data curation and other related BIO-IT services such as biological database development, software and data analysis. If your company outsources any of these services, we would like to present ourselves and would like to be part of your growth.

Vgenomics is an Indian company that aims to diagnose rare diseases with bioinformatics and artificial intelligence (AI). They are committed to addressing rare diseases and improving patient outcomes by analyzing complex genetic information. Vgenomics develops diagnostic and therapeutic solutions for inborn diseases, leveraging genomics and AI to bring novel solutions to the market for over 175 million children suffering from rare diseases.

Xcelris is India's leading genomics research organization offering cutting edge solutions to researchers across fields such as agriculture, human health, animal science, wildlife conservation, bio-energy, microbial and environmental genetics.